# OnCo record nct06733441 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06733441/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06733441", "NCT06733441" ;
  schema:name "A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma"@en ;
  schema:description "A phase 1 trial of Zeprumetostat run by Treeline Biosciences, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06733441/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06733441> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/zeprumetostat/> ;
  onco:companies <https://onco.cc/companies/treeline-biosciences/>, <https://onco.cc/companies/hengrui/> .